Literature DB >> 33495478

Unique structural solution from a VH3-30 antibody targeting the hemagglutinin stem of influenza A viruses.

Wayne D Harshbarger1, Derrick Deming1, Gordon J Lockbaum2, Nattapol Attatippaholkun1, Maliwan Kamkaew1, Shurong Hou2, Mohan Somasundaran2, Jennifer P Wang3, Robert W Finberg3, Quan Karen Zhu1, Celia A Schiffer4, Wayne A Marasco5,6.   

Abstract

Broadly neutralizing antibodies (bnAbs) targeting conserved influenza A virus (IAV) hemagglutinin (HA) epitopes can provide valuable information for accelerating universal vaccine designs. Here, we report structural details for heterosubtypic recognition of HA from circulating and emerging IAVs by the human antibody 3I14. Somatic hypermutations play a critical role in shaping the HCDR3, which alone and uniquely among VH3-30 derived antibodies, forms contacts with five sub-pockets within the HA-stem hydrophobic groove. 3I14 light-chain interactions are also key for binding HA and contribute a large buried surface area spanning two HA protomers. Comparison of 3I14 to bnAbs from several defined classes provide insights to the bias selection of VH3-30 antibodies and reveals that 3I14 represents a novel structural solution within the VH3-30 repertoire. The structures reported here improve our understanding of cross-group heterosubtypic binding activity, providing the basis for advancing immunogen designs aimed at eliciting a broadly protective response to IAV.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33495478      PMCID: PMC7835374          DOI: 10.1038/s41467-020-20879-6

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  65 in total

1.  The Quest for a Universal Flu Vaccine: Headless HA 2.0.

Authors:  Florian Krammer
Journal:  Cell Host Microbe       Date:  2015-10-14       Impact factor: 21.023

Review 2.  Targeting of somatic hypermutation.

Authors:  Valerie H Odegard; David G Schatz
Journal:  Nat Rev Immunol       Date:  2006-08       Impact factor: 53.106

3.  Inference of macromolecular assemblies from crystalline state.

Authors:  Evgeny Krissinel; Kim Henrick
Journal:  J Mol Biol       Date:  2007-05-13       Impact factor: 5.469

Review 4.  The biology of influenza viruses.

Authors:  Nicole M Bouvier; Peter Palese
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

5.  Rational HIV immunogen design to target specific germline B cell receptors.

Authors:  Joseph Jardine; Jean-Philippe Julien; Sergey Menis; Takayuki Ota; Oleksandr Kalyuzhniy; Andrew McGuire; Devin Sok; Po-Ssu Huang; Skye MacPherson; Meaghan Jones; Travis Nieusma; John Mathison; David Baker; Andrew B Ward; Dennis R Burton; Leonidas Stamatatos; David Nemazee; Ian A Wilson; William R Schief
Journal:  Science       Date:  2013-03-28       Impact factor: 47.728

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

Authors:  M E Reff; K Carner; K S Chambers; P C Chinn; J E Leonard; R Raab; R A Newman; N Hanna; D R Anderson
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

8.  Antibody recognition of a highly conserved influenza virus epitope.

Authors:  Damian C Ekiert; Gira Bhabha; Marc-André Elsliger; Robert H E Friesen; Mandy Jongeneelen; Mark Throsby; Jaap Goudsmit; Ian A Wilson
Journal:  Science       Date:  2009-02-26       Impact factor: 47.728

9.  Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.

Authors:  Cameron P Simmons; Nadia L Bernasconi; Amorsolo L Suguitan; Kimberly Mills; Jerrold M Ward; Nguyen Van Vinh Chau; Tran Tinh Hien; Federica Sallusto; Do Quang Ha; Jeremy Farrar; Menno D de Jong; Antonio Lanzavecchia; Kanta Subbarao
Journal:  PLoS Med       Date:  2007-05       Impact factor: 11.069

10.  A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve.

Authors:  Ying Fu; Zhen Zhang; Jared Sheehan; Yuval Avnir; Callie Ridenour; Thomas Sachnik; Jiusong Sun; M Jaber Hossain; Li-Mei Chen; Quan Zhu; Ruben O Donis; Wayne A Marasco
Journal:  Nat Commun       Date:  2016-09-13       Impact factor: 14.919

View more
  4 in total

Review 1.  Antibodies to combat viral infections: development strategies and progress.

Authors:  Giuseppe Pantaleo; Bruno Correia; Craig Fenwick; Victor S Joo; Laurent Perez
Journal:  Nat Rev Drug Discov       Date:  2022-06-20       Impact factor: 112.288

2.  Unique binding pattern for a lineage of human antibodies with broad reactivity against influenza A virus.

Authors:  Xiaoyu Sun; Caixuan Liu; Xiao Lu; Zhiyang Ling; Chunyan Yi; Zhen Zhang; Zi Li; Mingliang Jin; Wenshuai Wang; Shubing Tang; Fangfang Wang; Fang Wang; Sonam Wangmo; Shuangfeng Chen; Li Li; Liyan Ma; Yaguang Zhang; Zhuo Yang; Xiaoping Dong; Zhikang Qian; Jianping Ding; Dayan Wang; Yao Cong; Bing Sun
Journal:  Nat Commun       Date:  2022-05-02       Impact factor: 17.694

Review 3.  Protein engineering strategies for rational immunogen design.

Authors:  Timothy M Caradonna; Aaron G Schmidt
Journal:  NPJ Vaccines       Date:  2021-12-17       Impact factor: 7.344

4.  Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses.

Authors:  Osamu Kotani; Yasushi Suzuki; Shinji Saito; Akira Ainai; Akira Ueno; Takuya Hemmi; Kaori Sano; Koshiro Tabata; Masaru Yokoyama; Tadaki Suzuki; Hideki Hasegawa; Hironori Sato
Journal:  Viruses       Date:  2021-08-31       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.